Psychiatric co-morbidity in patients with hidradenitis suppurativa: A cross-sectional study of clinical characteristics and burden of disease

5Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Psychiatric co-morbidity (PCM) constitutes a major complicating factor for patients with hidradenitis suppurativa (HS) but individuals at risk are ill defined. Objectives: To examine the differences in demographic and clinical characteristics, co-morbidities, and disease burden in patients with HS with and without PCM. Methods: Data were obtained through clinical examination and interviews. Disease burden was evaluated based on clinical severity, VAS-10 for overall bother and pain, and dermatology life quality index. Analysis was conducted on all patients and amongst PCM-subgroups. All current physician diagnosed psychiatric conditions were included. Results: 667 consecutive, adult patients with HS from a dermatological university outpatient clinic were included. Of these, 183 (27.4 %) had a diagnosis of PCM, with affective disorders (16.2%) being most prevalent. PCM was associated with being unemployed (52.5 vs. 18.7 %) OR 5.50 (3.73–8.10) p < 0.001, Caucasian (88.5 vs. 80.6 %) OR 1.86 (1.12–3.09) p < 0.05, younger at HS-onset (23.6 vs. 26.2 years) p < 0.01, obese (44.0 vs. 34.5 %) OR 1.50 (1.06–2.13) p < 0.05 and smoker (89.6 vs. 73.2 %) OR 3.76 (2.20–6.40) p < 0.001. Differences within PCM-subgroups were also discovered. Patients with PCM were more likely to have asthma or/and chronic obstructive pulmonary disease (9.8 vs. 5.6 %) OR 1.94 (1.03–3.66) p < 0.05. Patients with PCM had higher VAS-10 bother scores (mean 7.3 vs. 6.7) p < 0.05, but no differences in disease severity. Patients with HS-onset before the age of 15 had the highest risk of developing PCM within the following 10 years, HR 3.37 (1.56–7.31) p = 0.002. Conclusions: Patients with PCM and HS vary in demographic and clinical characteristics, risk factors and burden of disease, compared to patients with HS without PCM. This calls for a multidisciplinary approach and increased awareness from the clinician.

Cite

CITATION STYLE

APA

Holgersen, N., Nielsen, V. W., Ring, H. C., Rosenø, N. A. L., Egeberg, A., Thyssen, J. P., & Thomsen, S. F. (2023). Psychiatric co-morbidity in patients with hidradenitis suppurativa: A cross-sectional study of clinical characteristics and burden of disease. JEADV Clinical Practice, 2(4), 994–1004. https://doi.org/10.1002/jvc2.222

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free